Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacovigilance01:19

Pharmacovigilance

1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

163
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
163
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

319
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
319
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

186
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
186

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effectiveness of low-dose SGLT2 inhibitors in diabetic patients with heart failure: a nationwide cohort study.

Frontiers in cardiovascular medicine·2026
Same author

Incidence and Risk of Common Vaccine Preventable Diseases among Transplant Recipients in Korea: A Nationwide Population-Based Study (2009-2020).

Infection & chemotherapy·2026
Same author

Association Between Preschool Physical Activity and Health Care Use and Burden in Children With Congenital Heart Disease.

Journal of the American Heart Association·2026
Same author

Association of Within-Visit Blood Pressure Changes With Cardiovascular Disease and Mortality Among Individuals Without a History of Hypertension: Results From the UK Biobank.

Journal of the American Heart Association·2026
Same author

Hepatic Fibro-inflammation Measured by MRI Iron-Corrected T1 Predicts Extrahepatic Cancer Risk: A UK Biobank Study.

Clinical and molecular hepatology·2026
Same author

Baricitinib for Itch-Dominant Atopic Dermatitis: A 52-week Baricitinib Real-World Experience in Korea.

Annals of dermatology·2026

相关实验视频

Updated: Jan 8, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

在自发报告数据库中检测药物相互作用信号的基于树的扫描统计.

Seok-Jae Heo1, Inkyung Jung1

  • 1Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.

Pharmaceutical statistics
|December 17, 2025
PubMed
概括

检测药物相互作用 (DDI) 对患者安全至关重要. 一种新的基于树的扫描统计方法改善了药物相互作用的不良事件信号的识别,并考虑了数据的复杂性.

科学领域:

  • 药物监督 药物监督 药物监督
  • 生物统计学 生物统计学
  • 计算生物学 计算生物学

背景情况:

  • 药物相互作用 (DDI) 对不良事件 (AE) 构成重大风险.
  • 由于临床试验和现有的统计方法的局限性,目前的安全监测正在努力识别DDI.
  • 现有的方法往往无法解释AE的等级性质和潜在的报告偏差.

研究的目的:

  • 开发用于检测DDI信号的先进统计方法.
  • 通过结合AE等级和报告偏差来解决现有方法的局限性.
  • 增强市场后药物安全监督.

主要方法:

  • 开发了一种新的统计方法,使用基于树的扫描统计数据.
  • 纳入了不良事件 (AE) 的等级结构.
  • 使用DDI的乘法相互作用模型减轻了报告偏差.

主要成果:

  • 提出的方法有效控制了I型错误率.
  • 在功率,灵敏度和错误发现率方面表现一致.
  • 即使在报告偏差的情况下,也表现出强的业绩.

结论:

关键词:
药物安全监测 监测药物安全层次结构结构是一个层次结构.互动是多重的互动.报告中的偏见信号检测 信号检测 信号检测

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

相关实验视频

Last Updated: Jan 8, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K
  • 新型基于树的扫描统计方法为DDI信号检测提供了有价值的工具.
  • 这种方法通过考虑AE等级和报告偏差来增强市场后药物安全监测.
  • 该方法提供了一种更准确,更可靠的方式来识别潜在的药物相互作用风险.